Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial RNA polymerase (RNAP) is the central enzyme of the bacterial transcription machinery, responsible for synthesizing all cellular RNA from a DNA template. The core enzyme is a multi-subunit complex composed of five subunits (two alpha, one beta, one beta-prime, and one omega), which associates with a dissociable sigma factor to form the transcriptionally competent holoenzyme. This machinery is highly conserved across bacterial species but structurally distinct from eukaryotic RNA polymerases, making it an excellent target for selective broad-spectrum and narrow-spectrum antibacterial therapies. Clinically approved drugs targeting this machinery include the rifamycins (such as rifampicin, rifabutin, and rifaximin), which bind to the beta-subunit and sterically block RNA elongation, and fidaxomicin, which inhibits transcription initiation. A major therapeutic challenge associated with targeting bacterial RNAP is the rapid emergence of drug resistance, primarily driven by single-nucleotide polymorphisms in the rpoB gene, as well as significant drug-drug interactions caused by the induction of hepatic cytochrome P450 enzymes by certain rifamycins.
Inhibition of bacterial transcription by binding to the RNA polymerase beta subunit to block RNA elongation, preventing transcription initiation by binding the DNA-RNAP complex, or inhibiting transcription termination factors like Rho.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial RNA polymerase (RNAP).